Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Administration: The drip is administered intravenously, taking around 3045 minutes per session
Avoid heat above 60C 0.00 - 0.00 Soluble in Water, Soluble in Ethanol, Soluble in DMSO (Dimethyl Sulfoxide) -
this effect is achieved by urging pancreas to secrete more insulin hormone
Dosing Comparison# Retatrutide Dosing# Based on Phase 2 clinical trial protocols (investigational only): Starting dose : 0.5 mg weekly subcutaneous injection Escalation : Gradual increase over 12-24 weeks to target dose (up to 12 mg) Target doses tested : 1, 4, 8, and 12 mg weekly Escalation rationale : Extended 24-week escalation for higher doses reduces GI side effects compared to faster 12-week escalation No commercial formulation exists
There is some research on GLP-1 receptor agonists, the class of drugs semaglutide belongs to, showing that they may influence parts of the brain involved in hormone control
